Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Heart Failure Management in Azerbaijan (CHF-AZ)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03390088
Recruitment Status : Recruiting
First Posted : January 4, 2018
Last Update Posted : July 10, 2019
Sponsor:
Information provided by (Responsible Party):
Prof. Dr. Mehdi Zoghi, World Heart Failure Society

Brief Summary:
This study is proposed to determined a national database of the etiologies, clinical and the demographic profile, using diagnostic tests and treatment of outpatients with chronic heart failure in Azerbaijan population.

Condition or disease
Heart Failure

Detailed Description:

Chronic heart failure remains the leading cause of hospitalization for those over the age of 65 and expected to increase over the next 25 years with advancing life span. Being a progressive syndrome, CHF decreases the quality of life and place an economic burden on health care system.

Advanced technologies in interventional cardiology, better organization of angiographic laboratories and primary prevention of coronary artery disease as the leading cause of HF, allowed warning its development in CAD patients. But the incidence and prevalence of CHF continue to increase with age as heart failure with preserved ejection fraction predominates in elderly patients. For the moment more than 23 million people over the world suffer from heart failure.

The prevalence of these patients remains very high even in USA - over 5.8 million.However, there is no any database for heart failure patient in Azerbaijan.The purpose of this study is to compose a national database of the etiologies, clinical and demographic characteristics, using diagnostic tests and management of outpatients heart failure in Azerbaijan population.


Layout table for study information
Study Type : Observational
Estimated Enrollment : 1000 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: The Clinical Profiles and Treatment Management of Chronic Heart Failure in Azerbaijan
Actual Study Start Date : January 28, 2018
Estimated Primary Completion Date : December 28, 2019
Estimated Study Completion Date : January 14, 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Heart Failure




Primary Outcome Measures :
  1. Heart failure related hospitalization [ Time Frame: 6 months ]
    Heart failure related hospitalization within 6 months



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 90 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
outpatients with chronic heart failure
Criteria

Inclusion :

  • Patients >18 years olds
  • Clinical diagnosis of heart failure
  • NYHA class II-IV heart failure

Exclusion :

  • Patients <18 years old
  • Failure to obtain informed consent
  • Pregnant or lactating

Previous cardiac transplantation


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03390088


Contacts
Layout table for location contacts
Contact: Yasmin Rustamova, MD, PhD +99450 2833653 yasmin.rst@gmail.com

Locations
Layout table for location information
Azerbaijan
Yasmin Rustamova Recruiting
Baku, Azerbaijan
Contact: Yasmin Rustamova         
Sponsors and Collaborators
Prof. Dr. Mehdi Zoghi

Layout table for additonal information
Responsible Party: Prof. Dr. Mehdi Zoghi, President of WHFS, World Heart Failure Society
ClinicalTrials.gov Identifier: NCT03390088     History of Changes
Other Study ID Numbers: 2018-1
First Posted: January 4, 2018    Key Record Dates
Last Update Posted: July 10, 2019
Last Verified: July 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Prof. Dr. Mehdi Zoghi, World Heart Failure Society:
Heart failure
Additional relevant MeSH terms:
Layout table for MeSH terms
Heart Failure
Heart Diseases
Cardiovascular Diseases